Eric A. Steckler, M.D. – FDA Inspection, Mar 30, 2018

Record Details

This FDA Inspection record concerns Eric A. Steckler, M.D., with an inspection on March 30, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Eric A. Steckler, M.D.
Inspection Date: March 30, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research
People: Gene R. Gunn (Company Rep)
Ladislav Kermet (Company Rep)
Michelle C Roberts (Issuing Officer)

View Company Profile

ID · ed73ef2b-663a-4b34-a260-42fd7e3bd849

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1046934
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Eric A. Steckler, M.D.

FDA Inspection

Eric A. Steckler, M.D.March 30, 2018